Nomenclature
CAS number: 122841-10-5
(6
R,7
R)-7-[[(2
Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[2,3-dihydro-2-(2-hydroxyethyl)-3-imino-1
H-pyrazol-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic
acid; (
syn)-7β-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-[3-amino-2-(2-hydroxyethyl)-1-pyrazolio]methyl-3-cephem-4-carboxylate; (-)-5-amino-2-[[(6
R,7
R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-(2-hydroxyethyl)pyrazolium
hydroxide inner salt 7
2-(
Z)-(
O-methyloxime).
C
19H
22N
8O
6S
2; mol wt 522.56.
C 43.67%, H 4.24%, N 21.44%, O 18.37%, S 12.27%.
Description and references
Fourth generation cephalosporin antibiotic.
Prepn: K. Sakane et al., EP 307804; eidem, US 4952578 (1989, 1990 both to Fujisawa); H. Ohki et al., J. Antibiot. 46, 359
(1993). In vitro activity and β-lactamase stability:
H. C. Neu et al., Antimicrob. Agents
Chemother. 37, 566 (1993). Clinical pharmacokinetics:
R. Wise et al., ibid. 38, 2369 (1994). Series of articles on activity, clinical
pharmacology and therapeutic efficacy: Chemotherapy
(Tokyo) 42, Suppl. 3, 1-464 (1994).
Antibacterial.